Omar Peza-Chavez

Omar Peza-Chavez

Auto-generated profile, based on publicly available information

Omar Peza-Chavez

Department of Bioengineering, McGill University, Montreal H3A 0G4, Quebec, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
JKJacqueline Kort-Mascort
Jacqueline Kort-Mascort
SFSalvador Flores-Torres
Salvador Flores-Torres
OPOmar Peza-Chavez
Omar Peza-Chavez
JJJoyce H. Jang
Joyce H. Jang
LPLucas Antonio Pardo
Lucas Antonio Pardo
JJoseph Kinsella
Joseph Kinsella
Decellularized extracellular matrix hydrogels are tissue-derived materials that with proper processing can be used for tissue engineering applications and to build tissue microenvironmentsin vitro. Figure was partly created with Servier Medical Art.

10 March 2021 in Biofabrication
Verified
Journal Article
Closed access
PDF file
SFSalvador Flores-Torres
Salvador Flores-Torres
OPOmar Peza-Chavez
Omar Peza-Chavez
HKHellen Kuasne
Hellen Kuasne
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
JKJacqueline Kort-Mascort
Jacqueline Kort-Mascort
JJoseph Kinsella
Joseph Kinsella
Hydrogels consisting of controlled fractions of alginate, gelatin, and Matrigel enable the development of patient-derived bioprinted tissue models that support cancer spheroid growth and expansion. These engineered models can be dissociated to be then reintroduced to new hydrogel solutions and subsequently reprinted to generate multigenerational models. The process of harvesting cells from 3D bioprinted models is possible by chelating the ions that crosslink alginate, causing the gel to weaken. Inclusion of the gelatin and Matrigel fractions to the hydrogel increases the bioactivity by providing cell-matrix binding sites and promoting cross-talk between cancer cells and their microenvironment. Here we show that immortalized triple-negative breast cancer cells (MDA-MB-231) and patient-derived gastric adenocarcinoma cells can be reprinted for at least three 21 d culture cycles following bioprinting in the alginate/gelatin/Matrigel hydrogels. Our drug testing results suggest that our 3D bioprinted model can also be used to recapitulate in vivo patient drug response. Furthermore, our results show that iterative bioprinting techniques coupled with alginate biomaterials can be used to maintain and expand patient-derived cancer spheroid cultures for extended periods without compromising cell viability, altering division rates, or disrupting cancer spheroid formation.

5 July 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SFSalvador Flores-Torres
Salvador Flores-Torres
NDNikolaos M. Dimitriou
Nikolaos M. Dimitriou
LPLucas Antonio Pardo
Lucas Antonio Pardo
JKJacqueline Kort-Mascort
Jacqueline Kort-Mascort
SPSanjima Pal
Sanjima Pal
JJoseph Kinsella
Joseph Kinsella

4 January 2023 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
SFSalvador Flores-Torres
Salvador Flores-Torres
TJTao Jiang
Tao Jiang
JKJacqueline Kort-Mascort
Jacqueline Kort-Mascort
YYYun Yang
Yun Yang
OPOmar Peza-Chavez
Omar Peza-Chavez
JJoseph Kinsella
Joseph Kinsella